← 產業報告目錄
Synthetic Lethality-based Drugs and Targets Market Size, Share & Trends Analysis Report By Type (Monotherapy, Combination Therapy), By Application (Medical Research Institution, Hospital and Clinic), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-09頁數 180報告編號 INSIGHTACE-f39d63f94c
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Synthetic Lethality-based Drugs and Targets Market is poised to surge at a compound annual growth rate of 14.5% throughout the 2025–2034 forecast period.
At its core, Synthetic Lethality-based Drugs and Targets pertains to a genetic and cancer treatment notion in which the simultaneous dysfunction of two genes results in cell death, whereas the dysfunction of either gene alone does not have. Stakeholders across the healthcare landscape are expandingly turning to these solutions to meet contemporary demands.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the expanding emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Synthetic Lethality-based Drugs and Targets Market Snapshot
Chapter 4. Global Synthetic Lethality-based Drugs and Targets Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
5.2.1. Monotherapy
5.2.2. Combination Therapy
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Medical Research Institution
6.2.2. Hospital and Clinic
6.2.3. Other
Chapter 7. Synthetic Lethality-based Drugs and Targets Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.1.2. North America Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.1.3. North America Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.2.2. Europe Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.2.3. Europe Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.3.2. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.3.3. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.4.2. Latin America Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.4.3. Latin America Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.5.2. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.5.3. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. AbbVie
8.2.2. AstraZeneca
8.2.3. BeiGene
8.2.4. Clovis Oncology
8.2.5. GlaxoSmithKline
8.2.6. Pfizer
8.2.7. AtlasMedx
8.2.8. Chordia Therapeutics
8.2.9. IDEAYA Biosciences
8.2.10. Mission Therapeutics
8.2.11. Repare Therapeutics
8.2.12. Sierra Oncology
8.2.13. SyntheX Labs
8.2.14. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們